ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
Dow Jones
42.392,27
-0,36%
Euro vs US Dollar
1,02696
0,02%
Bitcoin
96.826,13
-0,07%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Eton Pharmaceuticals Inc (ETON) Börsenkurse

Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc (ETON)

NASDAQ
14,31
0,99
(7,43%)
Geschlossen 03 Januar 10:00PM
Verzögert um 15 Minuten
14,9935
0,6835
(4,78%)
Nach Börsenschluss: 1:12AM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
14,9935
Gebot
14,03
Fragen
14,91
Volumen
437.898
13,28 Tagesbereich 15,00
3,03 52-Wochen-Bereich 14,9935
Marktkapitalisierung
387,375M
Handelsende
13,32
Handelsbeginn
13,40
Letzte Trade
4
@
14.83
Letzter Handelszeitpunkt
Finanzvolumen
US$ 6.209.659
VWAP
14,1806
Durchschnittliches Volumen (3 Mio.)
212.613
Ausgegebene Aktien
25.836.204
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-396,13
Gewinn pro Aktie (EPS)
-0,04
Erlöse
31,64M
Nettogewinn
-936k

Über Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.etonpharma.com
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Eton Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ETON. The last closing price for Eton Pharmaceuticals was US$13,32. Over the last year, Eton Pharmaceuticals shares have traded in a share price range of US$ 3,03 to US$ 14,9935.

Eton Pharmaceuticals currently has 25.836.204 shares in issue. The market capitalisation of Eton Pharmaceuticals is US$344,14 million. Eton Pharmaceuticals has a price to earnings ratio (PE ratio) of -396.13.

Option-Flow Eton Pharmaceuticals (ETON)

Vollständigen Option-Flow anzeigen

Gesamtfluss

Bullisch

Nettoprämie

28k

Calls / Puts

100.00%

Käuf. / Verkä.

100.00%

OTM / ITM

0.00%

Sweeps

0.00%

ETON Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

20 Dezember 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Acquisition bolsters Eton’s commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic...

20 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

17 Dezember 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

DEER PARK, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and...

17 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

12 Dezember 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

12 Dezember 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

09 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

03 Dezember 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Ms. Erdogan-Trinkaus brings a wealth of commercial leadership and expertise in sales and marketing from her tenure at leading global pharmaceutical companies and across the broader health and...

03 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

25 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
12.463519.660814046312.5314.993512.4214764813.25874135CS
42.713522.096905537512.2814.993511.6414718412.59978034CS
127.323595.4823989577.6714.99357.2521261310.7203931CS
2611.6335346.2351190483.3614.99353.221594258.5630205CS
5210.6935248.6860465124.314.99353.031106487.32901099CS
15610.6335243.8876146794.3614.99351.951349664.63968098CS
2607.7435106.8068965527.2514.99351.952073605.83584817CS

ETON - Frequently Asked Questions (FAQ)

What is the current Eton Pharmaceuticals share price?
The current share price of Eton Pharmaceuticals is US$ 14,9935
How many Eton Pharmaceuticals shares are in issue?
Eton Pharmaceuticals has 25.836.204 shares in issue
What is the market cap of Eton Pharmaceuticals?
The market capitalisation of Eton Pharmaceuticals is USD 344,14M
What is the 1 year trading range for Eton Pharmaceuticals share price?
Eton Pharmaceuticals has traded in the range of US$ 3,03 to US$ 14,9935 during the past year
What is the PE ratio of Eton Pharmaceuticals?
The price to earnings ratio of Eton Pharmaceuticals is -396,13
What is the cash to sales ratio of Eton Pharmaceuticals?
The cash to sales ratio of Eton Pharmaceuticals is 11,71
What is the reporting currency for Eton Pharmaceuticals?
Eton Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Eton Pharmaceuticals?
The latest annual turnover of Eton Pharmaceuticals is USD 31,64M
What is the latest annual profit for Eton Pharmaceuticals?
The latest annual profit of Eton Pharmaceuticals is USD -936k
What is the registered address of Eton Pharmaceuticals?
The registered address for Eton Pharmaceuticals is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Eton Pharmaceuticals website address?
The website address for Eton Pharmaceuticals is www.etonpharma.com
Which industry sector does Eton Pharmaceuticals operate in?
Eton Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ONCBeiGene Ltd
 184,21
(731,65%)
129,32k
RAINRain Enhancement Technologies Holdco Inc
 6,75
(457,85%)
212,43k
NITON2OFF Inc
US$ 1,07
(331,45%)
603,55M
CTCXCarmell Corporation
US$ 0,6991
(150,48%)
309,04M
TXMDTherapeuticsMD Inc
US$ 1,58
(83,72%)
7,4M
NMRANeumora Therapeutics Inc
US$ 1,965
(-81,46%)
44,29M
THCHTH International Limited
US$ 0,71
(-80,00%)
46,39k
MARXMars Acquisition Corporation
US$ 2,47
(-73,58%)
1,19M
SISIShineco Inc
US$ 2,07
(-54,30%)
1,73M
MARXUMars Acquisition Corporation
US$ 6,23
(-40,10%)
66,1k
NITON2OFF Inc
US$ 1,07
(331,45%)
603,55M
MBIOMustang Bio Inc
US$ 0,2093
(18,25%)
310,88M
CTCXCarmell Corporation
US$ 0,6991
(150,48%)
309,04M
CGBSCrown LNG Holdings Ltd
US$ 0,6749
(68,68%)
278,33M
SVMHSRIVARU Holding Ltd
US$ 0,0599
(42,28%)
275,21M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ETON
Eton Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten